Back to Markets
PAPalisade Bio Inc

Palisade Bio Inc

PALINASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$2.12

+0.0600 (+2.91%)

As of 05/29/26 EDT · USD

Compare
Low: $0.5300Current: $2.12High: $2.86

Key Statistics

Open

$2.06

Day High

$2.13

Day Low

$2.06

Prev. Close

$2.06

VolumeShares traded today.

735.34K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$367.99M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-1.81

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$2.86

52W LowLowest price over the past 52 weeks.

$0.5300

50D MAAverage closing price over the last 50 trading days.

$2.01

200D MAAverage closing price over the last 200 trading days.

$1.70

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+5.5%

1M

+9.8%

6M

-1.4%

YTD

-15.2%

1Y

+185.7%

About

Neuralstem Inc. is a biotechnology company headquartered in Rockville, Maryland that specializes in developing commercial-scale production of multiple types of central nervous system stem cells. In October 2019 Neuralstem announces that the company has changed its name to Seneca Biopharma, Inc. In April 2021 Seneca Biopharma merged with Leading BioSciences to form the combined company Palisade Bio, Inc.

palisadebio.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade PALI

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.